|
1.
|
DeVita VT, Lawrence TS, Rosenberg SA,
DePinho RA and Weinberg RA: DeVita, Hellman, and Rosenberg’s
Cancer: Principles and Practice of Oncology. 8th edition.
Lippncott: Williams & Wilkins; 2009
|
|
2.
|
Eley JW, Hill HA, Chen VW, et al: Racial
differences in survival from breast cancer. Results of the National
Cancer Institute Black/White Cancer Survival Study. JAMA. 272. pp.
947–954. 1994, View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
GLOBOCAN 2008/Cancer Incidence and
Mortality Worldwide in 2008. International Agency for Research on
Cancer. World Health Organization. http://globocan.iarc.fr/.
|
|
4.
|
Tsugane S and Sasazuki S: Diet and the
risk of gastric cancer: review of epidemiological evidence. Gastric
Cancer. 10:75–83. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Dunn JE: Cancer epidemiology in
populations of the United States - with emphasis on Hawaii and
California - and Japan. Cancer Res. 35:3240–3245. 1975.PubMed/NCBI
|
|
6.
|
Jänne PA, Engelman JA and Johnson BE:
Epidermal growth factor receptor mutations in non-small-cell lung
cancer: implications for treatment and tumor biology. J Clin Oncol.
23:3227–3234. 2005.PubMed/NCBI
|
|
7.
|
Bell DW, Lynch TJ, Haserlat SM, et al:
Epidermal growth factor receptor mutations and gene amplification
in non-small-cell lung cancer: molecular analysis of the
IDEAL/INTACT gefitinib trials. J Clin Oncol. 23:8081–8092. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Rai KR and Keating MJ: Chronic Lymphocytic
Leukemia Chapter 127 Cancer Medicine. 6th edition. BC Decker;
Hamilton, ON: 2000
|
|
9.
|
Redaelli A, Laskin BL, Stephens JM,
Botteman MF and Pashos CL: The clinical and epidemiological burden
of chronic lymphocytic leukaemia. Eur J Cancer Care. 13:279–287.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
SEER Stat Fact Sheets: Chronic Lymphocytic
Leukemia Surveillance epidemiology and end of results. National
Cancer Institute. http://seer.cancer.gov/statfacts/html/clyl.html.
|
|
11.
|
Gale RP, Cozen W, Goodman MT, Wang FF and
Bernstein L: Decreased chronic lymphocytic leukemia incidence in
Asians in Los Angeles County. Leuk Res. 24:665–669. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Pan JW, Cook LS, Schwartz SM and Weis NS:
Incidence of leukemia in Asian migrants to the United States and
their descendants. Cancer Causes Control. 13:791–795. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Hallek M, Cheson BD, Catovsky D, et al:
Guidelines for the diagnosis and treatment of chronic lymphocytic
leukemia: a report from the International Workshop on Chronic
Lymphocytic Leukemia updating the National Cancer Institute-Working
Group 1996 guidelines. Blood. 111:5446–5456. 2008. View Article : Google Scholar
|
|
14.
|
Nakahashi H, Tsukamoto N, Hashimoto Y, et
al: Characterization of immunoglobulin heavy and light chain gene
expression in chronic lymphocytic leukemia and related disorders.
Cancer Sci. 100:671–677. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Kawamata N, Ogawa S, Gueller S, et al:
Identified hidden genomic changes in mantle cell lymphoma using
high-resolution single nucleotide polymorphism genomic array. Exp
Hematol. 37:937–946. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Yamamoto G, Nannya Y, Kato M, et al:
Highly sensitive method for genomewide detection of allelic
composition in nonpaired, primary tumor specimens by use of
affymetrix single-nucleotide-polymorphism genotyping microarrays.
Am J Hum Genet. 81:114–126. 2007. View
Article : Google Scholar
|
|
17.
|
Lehmann S, Ogawa S, Raynaud SD, et al:
Molecular allelokaryo-typing of early-stage, untreated chronic
lymphocytic leukemia. Cancer. 112:1296–1305. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Caporaso N, Goldin L, Plass C, et al:
Chronic lymphocytic leukaemia genetics overview. Br J Haematol.
139:630–634. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Di Bernardo MC, Crowther-Swanepoel D,
Broderick P, et al: A genome-wide association study identifies six
susceptibility loci for chronic lymphocytic leukemia. Nat Genet.
40:1204–1210. 2008.
|
|
20.
|
Kitada S, Andersen J, Akar S, et al:
Expression of apoptosis-regulating proteins in chronic lymphocytic
leukemia: correlations with in vitro and in vivo chemoresponses.
Blood. 91:3379–3389. 1998.PubMed/NCBI
|
|
21.
|
Majid A, Tsoulakis O, Walewska R, et al:
BCL2 expression in chronic lymphocytic leukemia: lack of
association with the BCL2 938A>C promoter single nucleotide
polymorphism. Blood. 111:874–877. 1998.PubMed/NCBI
|
|
22.
|
Calin GA, Dumitru CD, Shimizu M, et al:
Frequent deletions and down-regulation of micro- RNA genes miR15
and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad
Sci USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Calin GA, Ferracin M, Cimmino A, et al: A
MicroRNA signature associated with prognosis and progression in
chronic lymphocytic leukemia. N Engl J Med. 353:1793–1801. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Calin GA and Croce CM: Chronic lymphocytic
leukemia: interplay between noncoding RNAs and protein-coding
genes. Blood. 114:4761–4770. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Cimmino A, Calin GA, Fabbri M, et al:
miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Abramson JS and Shipp MA: Advances in the
biology and therapy of diffuse large B-cell lymphoma: moving toward
a molecularly targeted approach. Blood. 106:1164–1174. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Basso K and Dalla-Favera R: BCL6: master
regulator of the germinal center reaction and key oncogene in B
cell lymphoma-genesis. Adv Immunol. 105:193–210. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Phan RT and Dalla-Favera R: The BCL6
proto-oncogene suppresses p53 expression in germinal-centre B
cells. Nature. 432:635–639. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Ching YP, Wong CM, Chan SF, et al: Deleted
in liver cancer (DLC) 2 encodes a RhoGAP protein with growth
suppressor function and is underexpressed in hepatocellular
carcinoma. J Biol Chem. 278:10824–10830. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Lahoz A and Hall A: DLC1: a significant
GAP in the cancer genome. Genes Dev. 22:1724–1730. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Yin XL, Pang JC and Ng HK: Identification
of a region of homozygous deletion on 8p22-23.1 in medulloblastoma.
Oncogene. 21:1461–1468. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Yuan BZ, Jefferson AM, Baldwin KT,
Thorgeirsson SS, Popescu NC and Reynolds SH: DLC-1 operates as a
tumor suppressor gene in human non-small cell lung carcinomas.
Oncogene. 23:1405–1411. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Zender L, Xue W, Zuber J, et al: An
oncogenomics-based in vivo RNAi screen identifies tumor suppressors
in liver cancer. Cell. 135:852–864. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Rinaldi A, Mian M, Chigrinova E, et al:
Genome-wide DNA profiling of marginal zone lymphomas identifies
subtype-specific lesions with an impact on the clinical outcome.
Blood. 117:1595–1604. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Tagawa H, Suguro M, Tsuzuki S, et al:
Comparison of genome profiles for identification of distinct
subgroups of diffuse large B-cell lymphoma. Blood. 106:1770–1777.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Swerdlow SH, Campo E, Harris NL, et al:
WHO Classification of Tumours of Haematopoietic and Lymphoid
Tissues. 4th edition. World Health Organization; 2008
|
|
37.
|
Martinon F and Tschopp J: Inflammatory
caspases and inflammasomes: master switches of inflammation. Cell
Death Differ. 14:10–22. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Davis BK, Wen H and Ting JP: The
inflammasome NLRs in immunity, inflammation, and associated
diseases. Annu Rev Immunol. 29:707–735. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Altshuler D, Daly MJ and Lander ES:
Genetic mapping in human disease. Science. 322:881–888. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Clifford RJ, Edmonson MN, Nguyen C,
Scherpbier T, Hu Y and Buetow KH: Bioinformatics tools for single
nucleotide polymorphism discovery and analysis. Ann NY Acad Sci.
1020:101–109. 2004. View Article : Google Scholar : PubMed/NCBI
|
